{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:24:44Z","timestamp":1790897084401,"version":"4.1.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1038\/nrneph.2009.13","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T01:43:29Z","timestamp":1238031809000},"page":"221-228","source":"Crossref","is-referenced-by-count":221,"title":["Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease"],"prefix":"10.1038","volume":"5","author":[{"given":"Tevfik","family":"Ecder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Schrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrneph200913_CR1","first-page":"502","volume-title":"Diseases of the Kidney and Urinary Tract","author":"T Ecder","year":"2007","unstructured":"Ecder, T. et al. in Diseases of the Kidney and Urinary Tract (ed. Schrier, R. W.) 502\u2013539. (Lippincott Williams & Wilkins, Philadelphia, 2007)."},{"key":"BFnrneph200913_CR2","unstructured":"PKD Foundation. Polycystic Kidney Disease: The Most Common Life-Threatening Genetic Disease. (Polycystic Kidney Research Foundation, Kansas City, 2000)."},{"key":"BFnrneph200913_CR3","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","volume":"5","author":"GM Fick","year":"1995","unstructured":"Fick, G. M. et al. Causes of death in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 5, 2048\u20132056 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","volume":"38","author":"RD Perrone","year":"2001","unstructured":"Perrone, R. D. et al. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am. J. Kidney Dis. 38, 777\u2013784 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR5","first-page":"653","volume":"11","author":"AB Chapman","year":"1991","unstructured":"Chapman, A. B. & Schrier, R. W. Pathogenesis of hypertension in autosomal dominant polycystic kidney disease. Semin. Nephrol. 11, 653\u2013660 (1991).","journal-title":"Semin. Nephrol."},{"key":"BFnrneph200913_CR6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1681\/ASN.V121194","volume":"12","author":"T Ecder","year":"2001","unstructured":"Ecder, T. & Schrier, R. W. Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J. Am. Soc. Nephrol. 12, 194\u2013200 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR7","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow, P. A. et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 41, 1311\u20131319 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR8","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","volume":"8","author":"AB Chapman","year":"1997","unstructured":"Chapman, A. B. et al. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 8, 1292\u20131297 (1997).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.amjhyper.2004.06.020","volume":"17","author":"CL Kelleher","year":"2004","unstructured":"Kelleher, C. L. et al. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. Am. J. Hypertens. 17, 1029\u20131034 (2004).","journal-title":"Am. J. Hypertens."},{"key":"BFnrneph200913_CR10","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1046\/j.1523-1755.2003.00264.x","volume":"64","author":"RW Schrier","year":"2003","unstructured":"Schrier, R. W. et al. The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease. Kidney Int. 64, 1792\u20131799 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR11","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ki.1987.98","volume":"31","author":"A Sedman","year":"1987","unstructured":"Sedman, A. et al. Autosomal dominant polycystic kidney disease in childhood: a longitudinal study. Kidney Int. 31, 1000\u20131005 (1987).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR12","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1681\/ASN.V491654","volume":"4","author":"GM Fick","year":"1994","unstructured":"Fick, G. M. et al. The spectrum of autosomal dominant polycystic kidney disease in children. J. Am. Soc. Nephrol. 4, 1654\u20131660 (1994).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR13","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1681\/ASN.V5122032","volume":"5","author":"DD Ivy","year":"1995","unstructured":"Ivy, D. D. et al. Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 5, 2032\u20132036 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR14","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1111\/j.1523-1755.2005.00678.x","volume":"68","author":"A Shamshirsaz","year":"2005","unstructured":"Shamshirsaz, A. et al. Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome. Kidney Int. 68, 2218\u20132224 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR15","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/ki.1990.330","volume":"38","author":"PA Gabow","year":"1990","unstructured":"Gabow, P. A. et al. Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int. 38, 1177\u20131180 (1990).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ki.1988.115","volume":"33","author":"PC Graham","year":"1988","unstructured":"Graham, P. C. & Lindop, G. B. M. The anatomy of the renin-secreting cell in adult polycystic kidney disease. Kidney Int. 33, 1084\u20131090 (1988).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ki.1992.297","volume":"42","author":"VE Torres","year":"1992","unstructured":"Torres, V. E. et al. Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. Kidney Int. 42, 364\u2013373 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR18","doi-asserted-by":"publisher","first-page":"F775","DOI":"10.1152\/ajprenal.00370.2003","volume":"287","author":"M Loghman-Adham","year":"2004","unstructured":"Loghman-Adham, M. et al. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am. J. Physiol. Renal Physiol. 287, F775\u2013F788 (2004).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph200913_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","volume":"323","author":"AB Chapman","year":"1990","unstructured":"Chapman, A. B. et al. The renin\u2013angiotensin\u2013aldosterone system and autosomal dominant polycystic kidney disease. N. Engl. J. Med. 323, 1091\u20131096 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph200913_CR20","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/S0025-6196(12)61724-8","volume":"66","author":"VE Torres","year":"1991","unstructured":"Torres, V. E. et al. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Mayo Clin. Proc. 66, 1010\u20131017 (1991).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrneph200913_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/ki.1992.28","volume":"41","author":"ML Watson","year":"1991","unstructured":"Watson, M. L. et al. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. Kidney Int. 41, 206\u2013210 (1991).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/01.hjh.0000222765.30348.0d","volume":"24","author":"TW Doulton","year":"2006","unstructured":"Doulton, T. W. et al. The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin\u2013angiotensin system in autosomal-dominant polycystic kidney disease patients. J. Hypertens. 24, 939\u2013945 (2006).","journal-title":"J. Hypertens."},{"key":"BFnrneph200913_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/ki.1991.238","volume":"40","author":"SB Harrap","year":"1991","unstructured":"Harrap, S. B. et al. Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease. Kidney Int. 40, 501\u2013508 (1991).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR24","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ki.1994.374","volume":"46","author":"BJ Barrett","year":"1994","unstructured":"Barrett, B. J. et al. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. Kidney Int. 46, 1118\u20131123 (1994).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0025-6196(12)65554-2","volume":"64","author":"VE Torres","year":"1989","unstructured":"Torres, V. E. et al. Natriuretic response to volume expansion in polycystic kidney disease. Mayo Clin. Proc. 64, 509\u2013515 (1989).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrneph200913_CR26","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1681\/ASN.V12112427","volume":"12","author":"IH Klein","year":"2001","unstructured":"Klein, I. H. et al. Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J. Am. Soc. Nephrol. 12, 2427\u20132433 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/00004872-199715050-00011","volume":"15","author":"G Bakris","year":"1997","unstructured":"Bakris, G. et al. Role of vasopressin in essential hypertension: racial differences. J. Hypertens. 15, 545\u2013550 (1997).","journal-title":"J. Hypertens."},{"key":"BFnrneph200913_CR28","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1210\/endo.143.7.8918","volume":"143","author":"S Fernandes","year":"2002","unstructured":"Fernandes, S. et al. Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension. Endocrinology 143, 2759\u20132766 (2002).","journal-title":"Endocrinology"},{"key":"BFnrneph200913_CR29","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/j.1523-1755.2005.00703.x","volume":"68","author":"VE Torres","year":"2005","unstructured":"Torres, V. E. Vasopressin antagonists in polycystic kidney disease. Kidney Int. 68, 2405\u20132418 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.0954-6820.1986.tb03330.x","volume":"219","author":"H Danielsen","year":"1986","unstructured":"Danielsen, H. et al. Expansion of extracellular volume in early polycystic kidney disease. Acta Med. Scand. 219, 399\u2013405 (1986).","journal-title":"Acta Med. Scand."},{"key":"BFnrneph200913_CR31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1681\/ASN.V971169","volume":"9","author":"B Hocher","year":"1998","unstructured":"Hocher, B. et al. Renal endothelin system in polycystic kidney disease. J. Am. Soc. Nephrol. 9, 1169\u20131177 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0272-6386(12)80212-5","volume":"24","author":"C Munemura","year":"1994","unstructured":"Munemura, C. et al. Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: Possible evidence of heterogeneity in cystogenesis. Am. J. Kidney Dis. 24, 561\u2013568 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000424407","volume":"115","author":"R Giusti","year":"1995","unstructured":"Giusti, R. et al. Plasma concentration of endothelin and arterial pressure in patients with ADPKD. Contrib. Nephrol. 115, 118\u2013121 (1995).","journal-title":"Contrib. Nephrol."},{"key":"BFnrneph200913_CR34","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.V1181371","volume":"11","author":"D Wang","year":"2000","unstructured":"Wang, D. et al. Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 11, 1371\u20131376 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR35","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","volume":"64","author":"D Wang","year":"2003","unstructured":"Wang, D. et al. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal dominant polycystic kidney disease. Kidney Int. 64, 1381\u20131388 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR36","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1046\/j.1523-1755.2003.00913.x","volume":"63","author":"MA Al-Nimri","year":"2003","unstructured":"Al-Nimri, M. A. et al. Endothelium-derived vasoactive mediators in polycystic kidney disease. Kidney Int. 63, 1776\u20131784 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.33549\/physiolres.930324","volume":"52","author":"M Merta","year":"2003","unstructured":"Merta, M. et al. Role of endothelin and nitric oxide in the pathogenesis of arterial hypertension in autosomal dominant polycystic kidney disease. Physiol. Res. 52, 433\u2013437 (2003).","journal-title":"Physiol. Res."},{"key":"BFnrneph200913_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1053\/j.ajkd.2007.09.020","volume":"51","author":"D Wang","year":"2008","unstructured":"Wang, D. et al. Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 51, 184\u2013191 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR39","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1053\/j.ajkd.2004.01.011","volume":"43","author":"O Kocaman","year":"2004","unstructured":"Kocaman, O. et al. Endothelial dysfunction and increased carotid intima\u2013media thickness in patients with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 43, 854\u2013860 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR40","doi-asserted-by":"publisher","first-page":"986","DOI":"10.2215\/CJN.02330607","volume":"3","author":"K Turkmen","year":"2008","unstructured":"Turkmen, K. et al. Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin. J. Am. Soc. Nephrol. 3, 986\u2013991 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000101369","volume":"27","author":"ML Borresen","year":"2007","unstructured":"Borresen, M. L. et al. Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function. Am. J. Nephrol. 27, 240\u2013246 (2007).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph200913_CR42","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1681\/ASN.V84616","volume":"8","author":"MD Griffin","year":"1997","unstructured":"Griffin, M. D. et al. Vascular expression of polycystin. J. Am. Soc. Nephrol. 8, 616\u2013626 (1997).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1681\/ASN.V1211","volume":"12","author":"VE Torres","year":"2001","unstructured":"Torres, V. E. et al. Vascular expression of polycystin-2. J. Am. Soc. Nephrol. 12, 1\u20139 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","volume":"114","author":"MJ Koren","year":"1991","unstructured":"Koren, M. J. et al. Relationship of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann. Intern. Med. 114, 345\u2013352 (1991).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneph200913_CR45","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1681\/ASN.V381451","volume":"3","author":"M Zeier","year":"1993","unstructured":"Zeier, M. et al. Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 3, 1451\u20131457 (1993).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR46","first-page":"211","volume":"56","author":"A Bardaji","year":"2002","unstructured":"Bardaji, A. et al. Cardiac involvement in autosomal dominant polycystic kidney disease: a hypertensive heart disease. Clin. Nephrol. 56, 211\u2013220 (2002).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph200913_CR47","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/ki.2008.397","volume":"74","author":"MA Cadnapaphornchai","year":"2008","unstructured":"Cadnapaphornchai, M. A. et al. Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension. Kidney Int. 74, 1192\u20131196 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR48","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/bmj.309.6969.1617","volume":"309","author":"A Saggar-Malik","year":"1994","unstructured":"Saggar-Malik, A. et al. Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease. BMJ 309, 1617\u20131618 (1994).","journal-title":"BMJ"},{"key":"BFnrneph200913_CR49","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0272-6386(98)70071-X","volume":"32","author":"A Bardaji","year":"1998","unstructured":"Bardaji, A. et al. Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 32, 970\u2013975 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR50","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1111\/j.1523-1755.2005.00682.x","volume":"68","author":"H Oflaz","year":"2005","unstructured":"Oflaz, H. et al. Biventricular diastolic dysfunction in patients with autosomal dominant polycystic kidney disease. Kidney Int. 68, 2244\u20132249 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR51","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/01.CIR.81.2.528","volume":"81","author":"P Verdecchia","year":"1990","unstructured":"Verdecchia, P. et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81, 528\u2013536 (1990).","journal-title":"Circulation"},{"key":"BFnrneph200913_CR52","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1093\/ndt\/12.10.2075","volume":"12","author":"TC Li Kam Wa","year":"1997","unstructured":"Li Kam Wa, T. C. et al. Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 12, 2075\u20132080 (1997).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph200913_CR53","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1681\/ASN.V1051020","volume":"10","author":"FA Valero","year":"1999","unstructured":"Valero, F. A. et al. Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 10, 1020\u20131026 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1053\/j.ajkd.2004.04.026","volume":"44","author":"A Martinez-Vea","year":"2004","unstructured":"Martinez-Vea, A. et al. Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state. Am. J. Kidney Dis. 44, 216\u2013223 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR55","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1053\/j.ajkd.2005.12.023","volume":"47","author":"EA Almeida","year":"2006","unstructured":"Almeida, E. A. et al. Tissue Doppler imaging in the evaluation of left ventricular function in young adults with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 47, 587\u2013592 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR56","first-page":"4284","volume":"83","author":"RA Phillips","year":"1998","unstructured":"Phillips, R. A. et al. Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. J. Clin. Endocrinol. Metab. 83, 4284\u20134288 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph200913_CR57","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1161\/01.HYP.27.3.729","volume":"27","author":"Y Ohya","year":"1996","unstructured":"Ohya, Y. et al. Hyperinsulinemia and left ventricular geometry in a work-site population in Japan. Hypertension 27, 729\u2013734 (1996).","journal-title":"Hypertension"},{"key":"BFnrneph200913_CR58","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ki.1997.360","volume":"52","author":"K Vareesangthip","year":"1997","unstructured":"Vareesangthip, K. et al. Insulin resistance in adult polycystic kidney disease. Kidney Int. 52, 503\u2013508 (1997).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR59","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0272-6386(03)00354-8","volume":"41","author":"A Lumiaho","year":"2003","unstructured":"Lumiaho, A. et al. Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1. Am. J. Kidney Dis. 41, 1219\u20131224 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR60","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/01.HYP.15.6.861","volume":"15","author":"AP Rocchini","year":"1990","unstructured":"Rocchini, A. P. et al. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 15, 861\u2013866 (1990).","journal-title":"Hypertension"},{"key":"BFnrneph200913_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI115842","volume":"90","author":"G Lembo","year":"1992","unstructured":"Lembo, G. et al. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J. Clin. Invest. 90, 24\u201329 (1992).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph200913_CR62","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0002-9149(96)00198-1","volume":"77","author":"AG Gharavi","year":"1996","unstructured":"Gharavi, A. G. et al. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am. J. Cardiol. 77, 1315\u20131319 (1996).","journal-title":"Am. J. Cardiol."},{"key":"BFnrneph200913_CR63","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0895-7061(99)00013-8","volume":"12","author":"RO Estacio","year":"1999","unstructured":"Estacio, R. O. et al. Deletion polymorphism of the angiotensin-converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus. Am. J. Hypertens. 12, 637\u2013643 (1999).","journal-title":"Am. J. Hypertens."},{"key":"BFnrneph200913_CR64","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ki.1997.373","volume":"52","author":"K Baboolal","year":"1997","unstructured":"Baboolal, K. et al. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int. 52, 607\u2013613 (1997).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR65","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0272-6386(99)70355-0","volume":"34","author":"L Perez-Oller","year":"1999","unstructured":"Perez-Oller, L. et al. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 34, 273\u2013278 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR66","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/ndt\/15.6.836","volume":"15","author":"MA Van Dijk","year":"2000","unstructured":"Van Dijk, M. A. et al. The ACE insertion\/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 15, 836\u2013839 (2000).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph200913_CR67","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1093\/ndt\/16.12.2323","volume":"16","author":"T Schiavello","year":"2001","unstructured":"Schiavello, T. et al. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 16, 2323\u20132327 (2001).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph200913_CR68","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1159\/000074653","volume":"23","author":"T Ecder","year":"2003","unstructured":"Ecder, T. et al. No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Am. J. Nephrol. 23, 466\u2013470 (2003).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph200913_CR69","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1056\/NEJM199209243271303","volume":"327","author":"AB Chapman","year":"1992","unstructured":"Chapman, A. B. et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 327, 916\u2013920 (1992).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph200913_CR70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1148\/radiology.191.1.8134594","volume":"191","author":"PM Ruggieri","year":"1994","unstructured":"Ruggieri, P. M. et al. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology 191, 33\u201339 (1994).","journal-title":"Radiology"},{"key":"BFnrneph200913_CR71","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/ndt\/17.5.819","volume":"17","author":"S Graf","year":"2002","unstructured":"Graf, S. et al. Intracranial aneurysms and dolichoectasia in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 17, 819\u2013823 (2002).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph200913_CR72","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1681\/ASN.V95837","volume":"9","author":"H Hadimeri","year":"1998","unstructured":"Hadimeri, H. et al. Coronary aneurysms in patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 9, 837\u2013841 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/ndt\/14.1.183","volume":"14","author":"NS Kanagasundaram","year":"1999","unstructured":"Kanagasundaram, N. S. et al. Aneurysm of the splenic artery in a patient with autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 14, 183\u2013184 (1999).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph200913_CR74","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1681\/ASN.V7112483","volume":"7","author":"R Torra","year":"1996","unstructured":"Torra, R. et al. Abdominal aortic aneurysms and autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 7, 2483\u20132486 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR75","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1053\/ajkd.2001.27694","volume":"38","author":"MM Belz","year":"2001","unstructured":"Belz, M. M. et al. Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 38, 770\u2013776 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR76","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1046\/j.1523-1755.2003.00918.x","volume":"63","author":"MM Belz","year":"2003","unstructured":"Belz, M. M. et al. Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int. 63, 1824\u20131830 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR77","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1440-1797.2006.00535.x","volume":"11","author":"RW Schrier","year":"2006","unstructured":"Schrier, R. W. Optimal care of autosomal dominant polycystic kidney disease patients. Nephrology 11, 124\u2013130 (2006).","journal-title":"Nephrology"},{"key":"BFnrneph200913_CR78","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/01.ASN.0000118527.74850.66","volume":"15","author":"RW Schrier","year":"2004","unstructured":"Schrier, R. W. et al. Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up. J. Am. Soc. Nephrol. 15, 1023\u20131028 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR79","doi-asserted-by":"publisher","first-page":"683","DOI":"10.7326\/0003-4819-100-5-683","volume":"100","author":"CV Leier","year":"1984","unstructured":"Leier, C. V. et al. Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann. Intern. Med. 100, 683\u2013688 (1984).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneph200913_CR80","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1056\/NEJM198810063191404","volume":"319","author":"KF Hossack","year":"1988","unstructured":"Hossack, K. F. et al. Echocardiographic findings in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 319, 907\u2013912 (1988).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph200913_CR81","first-page":"245","volume":"37","author":"M Timio","year":"1992","unstructured":"Timio, M. et al. The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: a 10-year follow-up in a five-generation kindred. Clin. Nephrol. 37, 245\u2013251 (1992).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph200913_CR82","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1053\/ajkd.2001.29216","volume":"38","author":"A Lumiaho","year":"2001","unstructured":"Lumiaho, A. et al. Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am. J. Kidney Dis. 38, 1208\u20131216 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR83","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","volume":"5","author":"S Klahr","year":"1995","unstructured":"Klahr, S. et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. J. Am. Soc. Nephrol. 5, 2037\u20132047 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR84","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1056\/NEJM199604113341502","volume":"334","author":"G Maschio","year":"1996","unstructured":"Maschio, G. et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N. Engl. J. Med. 334, 939\u2013945 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph200913_CR85","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0272-6386(00)70195-8","volume":"35","author":"T Ecder","year":"2000","unstructured":"Ecder, T. et al. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 35, 427\u2013432 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR86","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.V561349","volume":"5","author":"AB Chapman","year":"1994","unstructured":"Chapman, A. B. et al. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 5, 1349\u20131354 (1994).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR87","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/ndt\/gfg417","volume":"18","author":"MA Van Dijk","year":"2003","unstructured":"Van Dijk, M. A. et al. No effect of enalapril on progression in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 18, 2314\u20132320 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph200913_CR88","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/ndt\/gfm731","volume":"23","author":"R Zeltner","year":"2008","unstructured":"Zeltner, R. et al. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 23, 573\u2013579 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph200913_CR89","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1046\/j.1523-1755.2003.00776.x","volume":"63","author":"RW Schrier","year":"2003","unstructured":"Schrier, R. W. et al. Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int. 63, 678\u2013685 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR90","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/ajkd.2000.8970","volume":"36","author":"T Ecder","year":"2000","unstructured":"Ecder, T. et al. Progress in the blood pressure control in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 36, 266\u2013271 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200913_CR91","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000046231","volume":"21","author":"T Ecder","year":"2001","unstructured":"Ecder, T. et al. Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease. Am. J. Nephrol. 21, 98\u2013103 (2001).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph200913_CR92","doi-asserted-by":"publisher","first-page":"c18","DOI":"10.1159\/000081790","volume":"99","author":"K Nutahara","year":"2005","unstructured":"Nutahara, K. et al. Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease. Nephron Clin. Pract. 99, c18\u2013c23 (2005).","journal-title":"Nephron Clin. Pract."},{"key":"BFnrneph200913_CR93","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1523-1755.2005.00077.x","volume":"67","author":"TH Jafar","year":"2005","unstructured":"Jafar, T. H. et al. The effect of angiotensin-converting enzyme inhibitors on progression of advanced polycystic kidney disease. Kidney Int. 67, 265\u2013271 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph200913_CR94","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/ndt\/14.5.1113","volume":"14","author":"T Ecder","year":"1999","unstructured":"Ecder, T. et al. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 14, 1113\u20131116 (1999).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph200913_CR95","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1097\/01.ASN.0000018407.60002.B9","volume":"13","author":"R Schrier","year":"2002","unstructured":"Schrier, R. et al. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study. J. Am. Soc. Nephrol. 13, 1733\u20131739 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR96","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2215\/CJN.00060108","volume":"3","author":"AB Chapman","year":"2008","unstructured":"Chapman, A. B. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. Clin. J. Am. Soc. Nephrol. 3, 1197\u20131204 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph200913_CR97","unstructured":"Schrier, R. W. Renal volume, renin\u2013angiotensin\u2013aldosterone system, hypertension and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. (in press)."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.13","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrneph.2009.13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T22:52:24Z","timestamp":1710197544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2009.13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["BFnrneph200913"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2009.13","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}